{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T17:56:35Z","timestamp":1743011795802,"version":"3.40.3"},"publisher-location":"Cham","reference-count":101,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783319020952"},{"type":"electronic","value":"9783319020969"}],"license":[{"start":{"date-parts":[[2013,10,29]],"date-time":"2013-10-29T00:00:00Z","timestamp":1383004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2013,10,29]],"date-time":"2013-10-29T00:00:00Z","timestamp":1383004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014]]},"DOI":"10.1007\/978-3-319-02096-9_19","type":"book-chapter","created":{"date-parts":[[2013,11,19]],"date-time":"2013-11-19T03:02:24Z","timestamp":1384830144000},"page":"281-300","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Autoimmune Hepatitis"],"prefix":"10.1007","author":[{"given":"Diego","family":"Vergani","sequence":"first","affiliation":[]},{"given":"Rodrigo","family":"Liberal","sequence":"additional","affiliation":[]},{"given":"Giorgina","family":"Mieli-Vergani","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2013,10,29]]},"reference":[{"key":"19_CR1","first-page":"113","volume":"15","author":"J Waldenstr\u00f6m","year":"1950","unstructured":"Waldenstr\u00f6m J. Leber, Blutprotein und Nahrungseiweiss. Deutsch Gesellshaff Z Verdan Stoffwechselkr. 1950;15:113\u20139.","journal-title":"Deutsch Gesellshaff Z Verdan Stoffwechselkr"},{"key":"19_CR2","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0140-6736(56)91483-0","volume":"271","author":"IR Mackay","year":"1956","unstructured":"Mackay IR, Cowling DC, Taft LI. Lupoid hepatitis. Lancet. 1956;271:1323\u20136.","journal-title":"Lancet"},{"key":"19_CR3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/oxfordjournals.qjmed.a067264","volume":"40","author":"GC Cook","year":"1971","unstructured":"Cook GC, Mulligan R, Sherlock S. Controlled prospective trial of corticosteroid therapy in active chronic hepatitis. Q J Med. 1971;40:159\u201385.","journal-title":"Q J Med"},{"key":"19_CR4","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0016-5085(19)33223-8","volume":"63","author":"RD Soloway","year":"1972","unstructured":"Soloway RD, Summerskill WH, Baggenstoss AH, Geall MG, Gitnick GL, Elveback IR, et al. Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis. Gastroenterology. 1972;63:820\u201333.","journal-title":"Gastroenterology"},{"key":"19_CR5","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(73)92125-9","volume":"1","author":"IM Murray-Lyon","year":"1973","unstructured":"Murray-Lyon IM, Stern RB, Williams R. Controlled trial of prednisone and azathioprine in active chronic hepatitis. Lancet. 1973;1:735\u20137.","journal-title":"Lancet"},{"key":"19_CR6","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1749-6632.1965.tb19000.x","volume":"124","author":"IR Mackay","year":"1965","unstructured":"Mackay IR, Weiden S, Hasker J. Autoimmune hepatitis. Ann N Y Acad Sci. 1965;124:767\u201380.","journal-title":"Ann N Y Acad Sci"},{"key":"19_CR7","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/hep.1840180435","volume":"18","author":"PJ Johnson","year":"1993","unstructured":"Johnson PJ, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology. 1993;18:998\u20131005.","journal-title":"Hepatology"},{"key":"19_CR8","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","volume":"31","author":"F Alvarez","year":"1999","unstructured":"Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31:929\u201338.","journal-title":"J Hepatol"},{"key":"19_CR9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","volume":"48","author":"EM Hennes","year":"2008","unstructured":"Hennes EM, Zeniya M, Czaja AJ, Pares A, Dalekos GN, Krawitt EL, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48:169\u201376.","journal-title":"Hepatology"},{"key":"19_CR10","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.bpg.2011.09.009","volume":"25","author":"R Liberal","year":"2011","unstructured":"Liberal R, Longhi MS, Mieli-Vergani G, Vergani D. Pathogenesis of autoimmune hepatitis. Best Pract Res Clin Gastroenterol. 2011;25:653\u201364.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"19_CR11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/00365529850166284","volume":"33","author":"KM Boberg","year":"1998","unstructured":"Boberg KM, Aadland E, Jahnsen J, Raknerud N, Stiris M, Bell H. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand J Gastroenterol. 1998;33:99\u2013103.","journal-title":"Scand J Gastroenterol"},{"key":"19_CR12","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0210-5705(03)70452-X","volume":"27","author":"J Primo","year":"2004","unstructured":"Primo J, Merino C, Fernandez J, Moles JR, Llorca P, Hinojosa J. Incidence and prevalence of autoimmune hepatitis in the area of the Hospital de Sagunto (Spain). Gastroenterol Hepatol. 2004;27:239\u201343.","journal-title":"Gastroenterol Hepatol"},{"key":"19_CR13","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1111\/j.1572-0241.2002.06019.x","volume":"97","author":"KJ Hurlburt","year":"2002","unstructured":"Hurlburt KJ, McMahon BJ, Deubner H, Hsu-Trawinski B, Williams JL, Kowdley KV. Prevalence of autoimmune liver disease in Alaska Natives. Am J Gastroenterol. 2002;97:2402\u20137.","journal-title":"Am J Gastroenterol"},{"key":"19_CR14","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1111\/j.1440-1746.2010.06384.x","volume":"25","author":"JH Ngu","year":"2010","unstructured":"Ngu JH, Bechly K, Chapman BA, Burt MJ, Barclay ML, Gearry RB, et al. Population-based epidemiology study of autoimmune hepatitis: a disease of older women? J Gastroenterol Hepatol. 2010;25:1681\u20136.","journal-title":"J Gastroenterol Hepatol"},{"key":"19_CR15","first-page":"413","volume-title":"Autoimmune liver diseases","author":"SA Nishioka MaM","year":"1998","unstructured":"Nishioka MaM SA, McFarlane IG, et al. Geographical variation in the frequency and characteristics of autoimmune liver diseases. In: Krawitt EL, Wiesner RH, Nishioka M, editors. Autoimmune liver diseases. Amesterdam: Elsevier; 1998. p. 413\u201328."},{"key":"19_CR16","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jhep.2010.06.032","volume":"54","author":"D Qiu","year":"2011","unstructured":"Qiu D, Wang Q, Wang H, Xie Q, Zang G, Jiang H, et al. Validation of the simplified criteria for diagnosis of autoimmune hepatitis in Chinese patients. J Hepatol. 2011;54:340\u20137.","journal-title":"J Hepatol"},{"key":"19_CR17","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","volume":"51","author":"MP Manns","year":"2010","unstructured":"Manns MP, Czaja AJ, Gorham JD, Krawitt EL, Mieli-Vergani G, Vergani D, et al. Diagnosis and management of autoimmune hepatitis. Hepatology. 2010;51:2193\u2013213.","journal-title":"Hepatology"},{"key":"19_CR18","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jhep.2006.04.007","volume":"45","author":"T Al-Chalabi","year":"2006","unstructured":"Al-Chalabi T, Boccato S, Portmann BC, McFarlane IG, Heneghan MA. Autoimmune hepatitis (AIH) in the elderly: a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre. J Hepatol. 2006;45:575\u201383.","journal-title":"J Hepatol"},{"key":"19_CR19","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1136\/gut.2003.031732","volume":"53","author":"PT Donaldson","year":"2004","unstructured":"Donaldson PT. Genetics of liver disease: immunogenetics and disease pathogenesis. Gut. 2004;53:599\u2013608.","journal-title":"Gut"},{"key":"19_CR20","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1053\/gast.1997.v112.pm9178696","volume":"112","author":"MD Strettell","year":"1997","unstructured":"Strettell MD, Donaldson PT, Thomson LJ, Santrach PJ, Moore SB, Czaja AJ, et al. Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis. Gastroenterology. 1997;112:2028\u201335.","journal-title":"Gastroenterology"},{"key":"19_CR21","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1034\/j.1600-0528.2002.017401.x","volume":"174","author":"AJ Czaja","year":"2000","unstructured":"Czaja AJ, Donaldson PT. Genetic susceptibilities for immune expression and liver cell injury in autoimmune hepatitis. Immunol Rev. 2000;174:250\u20139.","journal-title":"Immunol Rev"},{"key":"19_CR22","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.autrev.2008.11.005","volume":"8","author":"C Duarte-Rey","year":"2009","unstructured":"Duarte-Rey C, Pardo AL, Rodriguez-Velosa Y, Mantilla RD, Anaya JM, Rojas-Villarraga A. HLA class II association with autoimmune hepatitis in Latin America: a meta-analysis. Autoimmun Rev. 2009;8:325\u201331.","journal-title":"Autoimmun Rev"},{"key":"19_CR23","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1053\/j.gastro.2005.12.020","volume":"130","author":"Y Ma","year":"2006","unstructured":"Ma Y, Bogdanos DP, Hussain MJ, Underhill J, Bansal S, Longhi MS, et al. Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2. Gastroenterology. 2006;130:868\u201382.","journal-title":"Gastroenterology"},{"key":"19_CR24","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.jhep.2004.02.023","volume":"40","author":"I Djilali-Saiah","year":"2004","unstructured":"Djilali-Saiah I, Renous R, Caillat-Zucman S, Debray D, Alvarez F. Linkage disequilibrium between HLA class II region and autoimmune hepatitis in pediatric patients. J Hepatol. 2004;40:904\u20139.","journal-title":"J Hepatol"},{"key":"19_CR25","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jhep.2006.07.034","volume":"45","author":"I Djilali-Saiah","year":"2006","unstructured":"Djilali-Saiah I, Fakhfakh A, Louafi H, Caillat-Zucman S, Debray D, Alvarez F. HLA class II influences humoral autoimmunity in patients with type 2 autoimmune hepatitis. J Hepatol. 2006;45:844\u201350.","journal-title":"J Hepatol"},{"key":"19_CR26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/hep.510310110","volume":"31","author":"K Agarwal","year":"2000","unstructured":"Agarwal K, Czaja AJ, Jones DE, Donaldson PT. Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis. Hepatology. 2000;31:49\u201353.","journal-title":"Hepatology"},{"key":"19_CR27","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0016-5085(99)70458-0","volume":"117","author":"AJ Czaja","year":"1999","unstructured":"Czaja AJ, Cookson S, Constantini PK, Clare M, Underhill JA, Donaldson PT. Cytokine polymorphisms associated with clinical features and treatment outcome in type 1 autoimmune hepatitis. Gastroenterology. 1999;117:645\u201352.","journal-title":"Gastroenterology"},{"key":"19_CR28","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1399-0039.2006.00794.x","volume":"69","author":"K Agarwal","year":"2007","unstructured":"Agarwal K, Czaja AJ, Donaldson PT. A functional Fas promoter polymorphism is associated with a severe phenotype in type 1 autoimmune hepatitis characterized by early development of cirrhosis. Tissue Antigens. 2007;69:227\u201335.","journal-title":"Tissue Antigens"},{"key":"19_CR29","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1053\/jhep.2002.30084","volume":"35","author":"A Vogel","year":"2002","unstructured":"Vogel A, Strassburg CP, Manns MP. Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis. Hepatology. 2002;35:126\u201331.","journal-title":"Hepatology"},{"key":"19_CR30","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/MPG.0b013e31818550de","volume":"48","author":"TO Lankisch","year":"2009","unstructured":"Lankisch TO, Mourier O, Sokal EM, Habes D, Lacaille F, Bridoux-Henno L, et al. AIRE gene analysis in children with autoimmune hepatitis type I or II. J Pediatr Gastroenterol Nutr. 2009;48:498\u2013500.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"19_CR31","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.4049\/jimmunol.162.3.1802","volume":"162","author":"GV Gregorio","year":"1999","unstructured":"Gregorio GV, Choudhuri K, Ma Y, Vegnente A, Mieli-Vergani G, Vergani D. Mimicry between the hepatitis B virus DNA polymerase and the antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis B virus infection. J Immunol. 1999;162:1802\u201310.","journal-title":"J Immunol"},{"key":"19_CR32","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1046\/j.1365-2249.2003.02229.x","volume":"133","author":"GV Gregorio","year":"2003","unstructured":"Gregorio GV, Choudhuri K, Ma Y, Pensati P, Iorio R, Grant P, et al. Mimicry between the hepatitis C virus polyprotein and antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis C virus infection. Clin Exp Immunol. 2003;133:404\u201313.","journal-title":"Clin Exp Immunol"},{"key":"19_CR33","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1136\/gut.45.3.435","volume":"45","author":"M Lenzi","year":"1999","unstructured":"Lenzi M, Bellentani S, Saccoccio G, Muratori P, Masutti F, Muratori L, et al. Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: a nested case-control study of the Dionysos cohort. Gut. 1999;45:435\u201341.","journal-title":"Gut"},{"key":"19_CR34","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.4049\/jimmunol.170.3.1481","volume":"170","author":"N Kerkar","year":"2003","unstructured":"Kerkar N, Choudhuri K, Ma Y, Mahmoud A, Bogdanos DP, Muratori L, et al. Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus\/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease. J Immunol. 2003;170:1481\u20139.","journal-title":"J Immunol"},{"key":"19_CR35","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/0016-5085(94)90426-X","volume":"106","author":"FD Mackie","year":"1994","unstructured":"Mackie FD, Peakman M, Yun M, Sallie R, Smith H, Davies ET, et al. Primary and secondary liver\/kidney microsomal autoantibody response following infection with hepatitis C virus. Gastroenterology. 1994;106:1672\u20135.","journal-title":"Gastroenterology"},{"key":"19_CR36","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jaut.2009.02.017","volume":"32","author":"N Agmon-Levin","year":"2009","unstructured":"Agmon-Levin N, Ram M, Barzilai O, Porat-Katz BS, Parikman R, Selmi C, et al. Prevalence of hepatitis C serum antibody in autoimmune diseases. J Autoimmun. 2009;32:261\u20136.","journal-title":"J Autoimmun"},{"key":"19_CR37","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/hep.23588","volume":"51","author":"E Bjornsson","year":"2010","unstructured":"Bjornsson E, Talwalkar J, Treeprasertsuk S, Kamath PS, Takahashi N, Sanderson S, et al. Drug-induced autoimmune hepatitis: clinical characteristics and prognosis. Hepatology. 2010;51:2040\u20138.","journal-title":"Hepatology"},{"key":"19_CR38","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1136\/adc.67.12.1447","volume":"67","author":"G Senaldi","year":"1992","unstructured":"Senaldi G, Portmann B, Mowat AP, Mieli-Vergani G, Vergani D. Immunohistochemical features of the portal tract mononuclear cell infiltrate in chronic aggressive hepatitis. Arch Dis Child. 1992;67:1447\u201353.","journal-title":"Arch Dis Child"},{"key":"19_CR39","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1146\/annurev.immunol.021908.132629","volume":"27","author":"IN Crispe","year":"2009","unstructured":"Crispe IN. The liver as a lymphoid organ. Annu Rev Immunol. 2009;27:147\u201363.","journal-title":"Annu Rev Immunol"},{"key":"19_CR40","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S0140-6736(84)91691-X","volume":"1","author":"S Vento","year":"1984","unstructured":"Vento S, Hegarty JE, Bottazzo G, Macchia E, Williams R, Eddleston AL. Antigen specific suppressor cell function in autoimmune chronic active hepatitis. Lancet. 1984;1:1200\u20134.","journal-title":"Lancet"},{"key":"19_CR41","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jhep.2004.03.008","volume":"41","author":"MS Longhi","year":"2004","unstructured":"Longhi MS, Ma Y, Bogdanos DP, Cheeseman P, Mieli-Vergani G, Vergani D. Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease. J Hepatol. 2004;41:31\u20137.","journal-title":"J Hepatol"},{"key":"19_CR42","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jaut.2005.05.001","volume":"25","author":"MS Longhi","year":"2005","unstructured":"Longhi MS, Ma Y, Mitry RR, Bogdanos DP, Heneghan M, Cheeseman P, et al. Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis. J Autoimmun. 2005;25:63\u201371.","journal-title":"J Autoimmun"},{"key":"19_CR43","doi-asserted-by":"crossref","first-page":"4484","DOI":"10.4049\/jimmunol.176.7.4484","volume":"176","author":"MS Longhi","year":"2006","unstructured":"Longhi MS, Hussain MJ, Mitry RR, Arora SK, Mieli-Vergani G, Vergani D, et al. Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis. J Immunol. 2006;176:4484\u201391.","journal-title":"J Immunol"},{"key":"19_CR44","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/hep.22071","volume":"47","author":"MS Longhi","year":"2008","unstructured":"Longhi MS, Meda F, Wang P, Samyn M, Mieli-Vergani G, Vergani D, et al. Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis. Hepatology. 2008;47:581\u201391.","journal-title":"Hepatology"},{"key":"19_CR45","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/hep.23792","volume":"52","author":"S Ferri","year":"2010","unstructured":"Ferri S, Longhi MS, De Molo C, Lalanne C, Muratori P, Granito A, et al. A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis. Hepatology. 2010;52:999\u20131007.","journal-title":"Hepatology"},{"key":"19_CR46","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/hep.24039","volume":"53","author":"MS Longhi","year":"2011","unstructured":"Longhi MS, Hussain MJ, Kwok WW, Mieli-Vergani G, Ma Y, Vergani D. Autoantigen-specific regulatory T cells, a potential tool for immune-tolerance reconstitution in type-2 autoimmune hepatitis. Hepatology. 2011;53:536\u201347.","journal-title":"Hepatology"},{"key":"19_CR47","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/hep.22914","volume":"50","author":"MS Longhi","year":"2009","unstructured":"Longhi MS, Mitry RR, Samyn M, Scalori A, Hussain MJ, Quaglia A, et al. Vigorous activation of monocytes in juvenile autoimmune liver disease escapes the control of regulatory T-cells. Hepatology. 2009;50:130\u201342.","journal-title":"Hepatology"},{"key":"19_CR48","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/hep.25682","volume":"56","author":"R Liberal","year":"2012","unstructured":"Liberal R, Grant CR, Holder B, Ma Y, Mieli-Vergani G, Vergani D, et al. The impaired immune regulation of autoimmune hepatitis is linked to a defective Galectin-9\/Tim-3 pathway. Hepatology. 2012;56:677\u201386.","journal-title":"Hepatology"},{"key":"19_CR49","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1053\/j.gastro.2012.02.041","volume":"142","author":"MS Longhi","year":"2012","unstructured":"Longhi MS, Liberal R, Holder B, Robson SC, Ma Y, Mieli-Vergani G, et al. Inhibition of interleukin-17 promotes differentiation of CD25- cells into stable T regulatory cells in patients with autoimmune hepatitis. Gastroenterology. 2012;142:1526\u201335.","journal-title":"Gastroenterology"},{"key":"19_CR50","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/hep.21658","volume":"46","author":"MS Longhi","year":"2007","unstructured":"Longhi MS, Hussain MJ, Bogdanos DP, Quaglia A, Mieli-Vergani G, Ma Y, et al. Cytochrome P450IID6-specific CD8 T cell immune responses mirror disease activity in autoimmune hepatitis type 2. Hepatology. 2007;46:472\u201384.","journal-title":"Hepatology"},{"key":"19_CR51","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/hep.20109","volume":"39","author":"P Lapierre","year":"2004","unstructured":"Lapierre P, Djilali-Saiah I, Vitozzi S, Alvarez F. A murine model of type 2 autoimmune hepatitis: xenoimmunization with human antigens. Hepatology. 2004;39:1066\u201374.","journal-title":"Hepatology"},{"key":"19_CR52","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1002\/hep.23536","volume":"51","author":"P Lapierre","year":"2010","unstructured":"Lapierre P, Beland K, Martin C, Alvarez Jr F, Alvarez F. Forkhead box p3+ regulatory T cell underlies male resistance to experimental type 2 autoimmune hepatitis. Hepatology. 2010;51:1789\u201398.","journal-title":"Hepatology"},{"key":"19_CR53","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/hep.26023","volume":"57","author":"P Lapierre","year":"2013","unstructured":"Lapierre P, Beland K, Yang R, Alvarez F. Adoptive transfer of ex vivo expanded regulatory T cells in an autoimmune hepatitis murine model restores peripheral tolerance. Hepatology. 2013;57:217\u201327.","journal-title":"Hepatology"},{"key":"19_CR54","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1084\/jem.20071859","volume":"205","author":"M Holdener","year":"2008","unstructured":"Holdener M, Hintermann E, Bayer M, Rhode A, Rodrigo E, Hintereder G, et al. Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection. J Exp Med. 2008;205:1409\u201322.","journal-title":"J Exp Med"},{"key":"19_CR55","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jaut.2008.04.015","volume":"31","author":"J Buxbaum","year":"2008","unstructured":"Buxbaum J, Qian P, Allen PM, Peters MG. Hepatitis resulting from liver-specific expression and recognition of self-antigen. J Autoimmun. 2008;31:208\u201315.","journal-title":"J Autoimmun"},{"key":"19_CR56","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.4049\/jimmunol.0803417","volume":"182","author":"RT Robinson","year":"2009","unstructured":"Robinson RT, Wang J, Cripps JG, Milks MW, English KA, Pearson TA, et al. End-organ damage in a mouse model of fulminant liver inflammation requires CD4+ T cell production of IFN-gamma but is independent of Fas. J Immunol. 2009;182:3278\u201384.","journal-title":"J Immunol"},{"key":"19_CR57","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1053\/j.gastro.2008.06.042","volume":"135","author":"M Kido","year":"2008","unstructured":"Kido M, Watanabe N, Okazaki T, Akamatsu T, Tanaka J, Saga K, et al. Fatal autoimmune hepatitis induced by concurrent loss of naturally arising regulatory T cells and PD-1-mediated signaling. Gastroenterology. 2008;135:1333\u201343.","journal-title":"Gastroenterology"},{"key":"19_CR58","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.3748\/wjg.14.3301","volume":"14","author":"EL Krawitt","year":"2008","unstructured":"Krawitt EL. Clinical features and management of autoimmune hepatitis. World J Gastroenterol. 2008;14:3301\u20135.","journal-title":"World J Gastroenterol"},{"key":"19_CR59","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s12016-010-8236-9","volume":"42","author":"D Vergani","year":"2012","unstructured":"Vergani D, Mieli-Vergani G. Cutting edge issues in autoimmune hepatitis. Clin Rev Allergy Immunol. 2012;42:309\u201321.","journal-title":"Clin Rev Allergy Immunol"},{"key":"19_CR60","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/hep.510250308","volume":"25","author":"GV Gregorio","year":"1997","unstructured":"Gregorio GV, Portmann B, Reid F, Donaldson PT, Doherty DG, McCartney M, et al. Autoimmune hepatitis in childhood: a 20-year experience. Hepatology. 1997;25:541\u20137.","journal-title":"Hepatology"},{"key":"19_CR61","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S1542-3565(04)00246-0","volume":"2","author":"WR Kessler","year":"2004","unstructured":"Kessler WR, Cummings OW, Eckert G, Chalasani N, Lumeng L, Kwo PY. Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis. Clin Gastroenterol Hepatol. 2004;2:625\u201331.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"19_CR62","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMra050408","volume":"354","author":"EL Krawitt","year":"2006","unstructured":"Krawitt EL. Autoimmune hepatitis. N Engl J Med. 2006;354:54\u201366.","journal-title":"N Engl J Med"},{"key":"19_CR63","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S1542-3565(04)00245-9","volume":"2","author":"D Samuel","year":"2004","unstructured":"Samuel D, Riordan S, Strasser S, Kurtovic J, Singh-Grewel I, Koorey D. Severe autoimmune hepatitis first presenting in the early post partum period. Clin Gastroenterol Hepatol. 2004; 2:622\u20134.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"19_CR64","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/gut.48.1.97","volume":"48","author":"MA Heneghan","year":"2001","unstructured":"Heneghan MA, Norris SM, O\u2019Grady JG, Harrison PM, McFarlane IG. Management and outcome of pregnancy in autoimmune hepatitis. Gut. 2001;48:97\u2013102.","journal-title":"Gut"},{"key":"19_CR65","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/hep.22432","volume":"48","author":"AD Yeoman","year":"2008","unstructured":"Yeoman AD, Al-Chalabi T, Karani JB, Quaglia A, Devlin J, Mieli-Vergani G, et al. Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: implications for follow-up and screening. Hepatology. 2008;48:863\u201370.","journal-title":"Hepatology"},{"key":"19_CR66","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s10620-010-1444-6","volume":"56","author":"RJ Wong","year":"2011","unstructured":"Wong RJ, Gish R, Frederick T, Bzowej N, Frenette C. Development of hepatocellular carcinoma in autoimmune hepatitis patients: a case series. Dig Dis Sci. 2011;56:578\u201385.","journal-title":"Dig Dis Sci"},{"key":"19_CR67","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jhep.2004.08.002","volume":"41","author":"D Vergani","year":"2004","unstructured":"Vergani D, Alvarez F, Bianchi FB, Cancado EL, Mackay IR, Manns MP, et al. Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group. J Hepatol. 2004;41:677\u201383.","journal-title":"J Hepatol"},{"key":"19_CR68","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1002\/art.1780400909","volume":"40","author":"EM Tan","year":"1997","unstructured":"Tan EM, Feltkamp TE, Smolen JS, Butcher B, Dawkins R, Fritzler MJ, et al. Range of antinuclear antibodies in \u201chealthy\u201d individuals. Arthritis Rheum. 1997;40:1601\u201311.","journal-title":"Arthritis Rheum"},{"key":"19_CR69","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1080\/0891693021000054066","volume":"35","author":"P Muratori","year":"2002","unstructured":"Muratori P, Muratori L, Agostinelli D, Pappas G, Veronesi L, Granito A, et al. Smooth muscle antibodies and type 1 autoimmune hepatitis. Autoimmunity. 2002;35:497\u2013500.","journal-title":"Autoimmunity"},{"key":"19_CR70","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/0016-5085(93)90160-E","volume":"105","author":"AJ Czaja","year":"1993","unstructured":"Czaja AJ, Carpenter HA, Manns MP. Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis. Gastroenterology. 1993;105:1522\u20138.","journal-title":"Gastroenterology"},{"key":"19_CR71","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/hep.22380","volume":"48","author":"C O\u2019Brien","year":"2008","unstructured":"O\u2019Brien C, Joshi S, Feld JJ, Guindi M, Dienes HP, Heathcote EJ. Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis. Hepatology. 2008;48:550\u20136.","journal-title":"Hepatology"},{"key":"19_CR72","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1111\/j.1440-1746.2006.04434.x","volume":"21","author":"S Nezu","year":"2006","unstructured":"Nezu S, Tanaka A, Yasui H, Imamura M, Nakajima H, Ishida H, et al. Presence of antimitochondrial autoantibodies in patients with autoimmune hepatitis. J Gastroenterol Hepatol. 2006;21:1448\u201354.","journal-title":"J Gastroenterol Hepatol"},{"key":"19_CR73","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00109-001-0306-2","volume":"80","author":"A Vogel","year":"2002","unstructured":"Vogel A, Strassburg CP, Obermayer-Straub P, Brabant G, Manns MP. The genetic background of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy and its autoimmune disease components. J Mol Med. 2002;80:201\u201311.","journal-title":"J Mol Med"},{"key":"19_CR74","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1073\/pnas.84.2.551","volume":"84","author":"P Beaune","year":"1987","unstructured":"Beaune P, Dansette PM, Mansuy D, Kiffel L, Finck M, Amar C, et al. Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug. Proc Natl Acad Sci U S A. 1987;84:551\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"19_CR75","first-page":"232","volume":"54","author":"O Crivelli","year":"1983","unstructured":"Crivelli O, Lavarini C, Chiaberge E, Amoroso A, Farci P, Negro F, et al. Microsomal autoantibodies in chronic infection with the HBsAg associated delta (delta) agent. Clin Exp Immunol. 1983;54:232\u20138.","journal-title":"Clin Exp Immunol"},{"key":"19_CR76","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/hep.1840160407","volume":"16","author":"N Abuaf","year":"1992","unstructured":"Abuaf N, Johanet C, Chretien P, Martini E, Soulier E, Laperche S, et al. Characterization of the liver cytosol antigen type 1 reacting with autoantibodies in chronic active hepatitis. Hepatology. 1992;16:892\u20138.","journal-title":"Hepatology"},{"key":"19_CR77","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gut.36.5.749","volume":"36","author":"M Lenzi","year":"1995","unstructured":"Lenzi M, Manotti P, Muratori L, Cataleta M, Ballardini G, Cassani F, et al. Liver cytosolic 1 antigen-antibody system in type 2 autoimmune hepatitis and hepatitis C virus infection. Gut. 1995;36:749\u201354.","journal-title":"Gut"},{"key":"19_CR78","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0016-5085(99)70186-1","volume":"116","author":"P Lapierre","year":"1999","unstructured":"Lapierre P, Hajoui O, Homberg JC, Alvarez F. Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis. Gastroenterology. 1999;116:643\u20139.","journal-title":"Gastroenterology"},{"key":"19_CR79","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/S0140-6736(00)02166-8","volume":"355","author":"I Wies","year":"2000","unstructured":"Wies I, Brunner S, Henninger J, Herkel J, Kanzler S, Meyer zum Buschenfelde KH, et al. Identification of target antigen for SLA\/LP autoantibodies in autoimmune hepatitis. Lancet. 2000;355:1510\u20135.","journal-title":"Lancet"},{"key":"19_CR80","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0140-6736(87)92024-1","volume":"1","author":"M Manns","year":"1987","unstructured":"Manns M, Gerken G, Kyriatsoulis A, Staritz M, Meyer zum Buschenfelde KH, et al. Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen. Lancet. 1987;1:292\u20134.","journal-title":"Lancet"},{"key":"19_CR81","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1053\/jhep.2002.32092","volume":"35","author":"Y Ma","year":"2002","unstructured":"Ma Y, Okamoto M, Thomas MG, Bogdanos DP, Lopes AR, Portmann B, et al. Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease. Hepatology. 2002;35:658\u201364.","journal-title":"Hepatology"},{"key":"19_CR82","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1055\/s-0029-1233533","volume":"29","author":"DP Bogdanos","year":"2009","unstructured":"Bogdanos DP, Mieli-Vergani G, Vergani D. Autoantibodies and their antigens in autoimmune hepatitis. Semin Liver Dis. 2009;29:241\u201353.","journal-title":"Semin Liver Dis"},{"key":"19_CR83","first-page":"347","volume":"55","author":"IG McFarlane","year":"1984","unstructured":"McFarlane IG, McFarlane BM, Major GN, Tolley P, Williams R. Identification of the hepatic asialo-glycoprotein receptor (hepatic lectin) as a component of liver specific membrane lipoprotein (LSP). Clin Exp Immunol. 1984;55:347\u201354.","journal-title":"Clin Exp Immunol"},{"key":"19_CR84","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1055\/s-2002-35704","volume":"22","author":"CP Strassburg","year":"2002","unstructured":"Strassburg CP, Manns MP. Autoantibodies and autoantigens in autoimmune hepatitis. Semin Liver Dis. 2002;22:339\u201352.","journal-title":"Semin Liver Dis"},{"key":"19_CR85","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/0016-5085(94)90129-5","volume":"107","author":"U Treichel","year":"1994","unstructured":"Treichel U, McFarlane BM, Seki T, Krawitt EL, Alessi N, Stickel F, et al. Demographics of anti-asialoglycoprotein receptor autoantibodies in autoimmune hepatitis. Gastroenterology. 1994;107:799\u2013804.","journal-title":"Gastroenterology"},{"key":"19_CR86","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0168-8278(05)80176-X","volume":"19","author":"U Treichel","year":"1993","unstructured":"Treichel U, Gerken G, Rossol S, Rotthauwe HW, Meyer zum Buschenfelde KH, Poralla T. Autoantibodies against the human asialoglycoprotein receptor: effects of therapy in autoimmune and virus-induced chronic active hepatitis. J Hepatol. 1993;19:55\u201363.","journal-title":"J Hepatol"},{"key":"19_CR87","first-page":"415","volume-title":"Pathology of the liver","author":"AJ Czaja","year":"2001","unstructured":"Czaja AJ, Carpenter HA. Autoimmune hepatitis. In: Macsween RNM, Burt AD, Portmann BC, editors. Pathology of the liver. London: Churchill Livingstone; 2001. p. 415\u201334."},{"key":"19_CR88","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/jhep.2001.22131","volume":"33","author":"GV Gregorio","year":"2001","unstructured":"Gregorio GV, Portmann B, Karani J, Harrison P, Donaldson PT, Vergani D, et al. Autoimmune hepatitis\/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study. Hepatology. 2001;33:544\u201353.","journal-title":"Hepatology"},{"key":"19_CR89","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1517\/14656566.2011.524206","volume":"12","author":"D Vergani","year":"2011","unstructured":"Vergani D, Mieli-Vergani G. Pharmacological management of autoimmune hepatitis. Expert Opin Pharmacother. 2011;12:607\u201313.","journal-title":"Expert Opin Pharmacother"},{"key":"19_CR90","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1478-3231.2005.01141.x","volume":"25","author":"S Seela","year":"2005","unstructured":"Seela S, Sheela H, Boyer JL. Autoimmune hepatitis type 1: safety and efficacy of prolonged medical therapy. Liver Int. 2005;25:734\u20139.","journal-title":"Liver Int"},{"key":"19_CR91","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/hep.1840100110","volume":"10","author":"KK Wang","year":"1989","unstructured":"Wang KK, Czaja AJ, Beaver SJ, Go VL. Extrahepatic malignancy following long-term immunosuppressive therapy of severe hepatitis B surface antigen-negative chronic active hepatitis. Hepatology. 1989;10:39\u201343.","journal-title":"Hepatology"},{"key":"19_CR92","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1365-2036.2010.04241.x","volume":"31","author":"AD Yeoman","year":"2010","unstructured":"Yeoman AD, Longhi MS, Heneghan MA. Review article: the modern management of autoimmune hepatitis. Aliment Pharmacol Ther. 2010;31:771\u201387.","journal-title":"Aliment Pharmacol Ther"},{"key":"19_CR93","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jhep.2012.11.010","volume":"58","author":"C Weiler-Normann","year":"2013","unstructured":"Weiler-Normann C, Schramm C, Quaas A, Wiegard C, Glaubke C, Pannicke N, et al. Infliximab as a rescue-treatment in difficult-to-treat autoimmune hepatitis. J Hepatol. 2013;58:529\u201332.","journal-title":"J Hepatol"},{"key":"19_CR94","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1002\/hep.23834","volume":"52","author":"C Efe","year":"2010","unstructured":"Efe C, Purnak T, Ozaslan E, Wahlin S. Drug-induced autoimmune hepatitis caused by anti-tumor necrosis factor alpha agents. Hepatology. 2010;52:2246\u20137.","journal-title":"Hepatology"},{"key":"19_CR95","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1159\/000322693","volume":"4","author":"E Barth","year":"2010","unstructured":"Barth E, Clawson J. A case of autoimmune hepatitis treated with rituximab. Case Rep Gastroenterol. 2010;4:502\u20139.","journal-title":"Case Rep Gastroenterol"},{"key":"19_CR96","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1053\/j.gastro.2010.06.046","volume":"139","author":"MP Manns","year":"2010","unstructured":"Manns MP, Woynarowski M, Kreisel W, Lurie Y, Rust C, Zuckerman E, et al. Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis. Gastroenterology. 2010;139:1198\u2013206.","journal-title":"Gastroenterology"},{"key":"19_CR97","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1053\/jhep.2003.50266","volume":"38","author":"W Hempfling","year":"2003","unstructured":"Hempfling W, Grunhage F, Dilger K, Reichel C, Beuers U, Sauerbruch T. Pharmacokinetics and pharmacodynamic action of budesonide in early- and late-stage primary biliary cirrhosis. Hepatology. 2003;38:196\u2013202.","journal-title":"Hepatology"},{"key":"19_CR98","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1053\/jhep.2000.16666","volume":"32","author":"DJ Reich","year":"2000","unstructured":"Reich DJ, Fiel I, Guarrera JV, Emre S, Guy SR, Schwartz ME, et al. Liver transplantation for autoimmune hepatitis. Hepatology. 2000;32:693\u2013700.","journal-title":"Hepatology"},{"key":"19_CR99","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/00007890-198404000-00009","volume":"37","author":"J Neuberger","year":"1984","unstructured":"Neuberger J, Portmann B, Calne R, Williams R. Recurrence of autoimmune chronic active hepatitis following orthotopic liver grafting. Transplantation. 1984;37:363\u20135.","journal-title":"Transplantation"},{"key":"19_CR100","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.cgh.2011.10.028","volume":"10","author":"R Liberal","year":"2012","unstructured":"Liberal R, Longhi MS, Grant CR, Mieli-Vergani G, Vergani D. Autoimmune hepatitis after liver transplantation. Clin Gastroenterol Hepatol. 2012;10:346\u201353.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"19_CR101","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0140-6736(97)06478-7","volume":"351","author":"N Kerkar","year":"1998","unstructured":"Kerkar N, Hadzic N, Davies ET, Portmann B, Donaldson PT, Rela M, et al. De-novo autoimmune hepatitis after liver transplantation. Lancet. 1998;351:409\u201313.","journal-title":"Lancet"}],"container-title":["Liver Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-02096-9_19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,19]],"date-time":"2024-05-19T18:01:26Z","timestamp":1716141686000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-319-02096-9_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,29]]},"ISBN":["9783319020952","9783319020969"],"references-count":101,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-02096-9_19","relation":{},"subject":[],"published":{"date-parts":[[2013,10,29]]},"assertion":[{"value":"29 October 2013","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}